Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.
about
Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neuronsChanging the face of kynurenines and neurotoxicity: therapeutic considerationsSpotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapy.Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs.Safinamide for the treatment of Parkinson's disease.Promising therapeutic agents for the treatment of Parkinson's disease.
P2860
Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Some molecular mechanisms of d ...... ioning in Parkinson's disease.
@en
type
label
Some molecular mechanisms of d ...... ioning in Parkinson's disease.
@en
prefLabel
Some molecular mechanisms of d ...... ioning in Parkinson's disease.
@en
P2093
P2860
P50
P1476
Some molecular mechanisms of d ...... tioning in Parkinson's disease
@en
P2093
Dénes Zádori
Ferenc Fülöp
József Toldi
P2860
P2888
P304
P356
10.1007/S00702-012-0930-8
P577
2012-11-30T00:00:00Z